Literature DB >> 22808963

Prostate cancer--uncertainty and a way forward.

Ian M Thompson, Catherine M Tangen.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22808963     DOI： 10.1056/NEJMe1205012

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  19 in total

Review 1.  Turning off AKT: PHLPP as a drug target.

Authors:  Alexandra C Newton; Lloyd C Trotman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014       Impact factor: 13.820

2.  [Radical prostatectomy versus observation for localized prostate cancer].

Authors:  M Bremer
Journal:  Strahlenther Onkol       Date:  2012-12       Impact factor: 3.621

3.  Screening and efficacy of radical prostatectomy.

Authors:  Michael Froehner
Journal:  Asian J Androl       Date:  2013-04-15       Impact factor: 3.285

4.  ESTIMATING PERSON-CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS.

Authors:  Anirban Basu
Journal:  J Appl Econ (Chichester Engl)       Date:  2014 June/July

Review 5.  Can we deliver randomized trials of focal therapy in prostate cancer?

Authors:  Hashim U Ahmed; Viktor Berge; David Bottomley; William Cross; Rakesh Heer; Richard Kaplan; Tom Leslie; Chris Parker; Clare Relton; Richard Stephens; Matthew R Sydes; Lindsay Turnbull; Jan van der Meulen; Andrew Vickers; Timothy Wilt; Mark Emberton
Journal:  Nat Rev Clin Oncol       Date:  2014-04-22       Impact factor: 66.675

6.  Addressing overdiagnosis and overtreatment in cancer: a prescription for change.

Authors:  Laura J Esserman; Ian M Thompson; Brian Reid; Peter Nelson; David F Ransohoff; H Gilbert Welch; Shelley Hwang; Donald A Berry; Kenneth W Kinzler; William C Black; Mina Bissell; Howard Parnes; Sudhir Srivastava
Journal:  Lancet Oncol       Date:  2014-05       Impact factor: 41.316

7.  p16 upregulation is linked to poor prognosis in ERG negative prostate cancer.

Authors:  Christoph Burdelski; Tatsiana Dieckmann; Asmus Heumann; Claudia Hube-Magg; Martina Kluth; Burkhard Beyer; Thomas Steuber; Raisa Pompe; Markus Graefen; Ronald Simon; Sarah Minner; Maria Christina Tsourlakis; Christina Koop; Jakob Izbicki; Guido Sauter; Till Krech; Thorsten Schlomm; Waldemar Wilczak; Patrick Lebok
Journal:  Tumour Biol       Date:  2016-07-21

Review 8.  Does robotic prostatectomy meet its promise in the management of prostate cancer?

Authors:  Kuo-How Huang; Stacey C Carter; Jim C Hu
Journal:  Curr Urol Rep       Date:  2013-06       Impact factor: 3.092

9.  VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy.

Authors:  Maria Christina Tsourlakis; Puya Khosrawi; Philipp Weigand; Martina Kluth; Claudia Hube-Magg; Sarah Minner; Christina Koop; Markus Graefen; Hans Heinzer; Corinna Wittmer; Guido Sauter; Till Krech; Waldemar Wilczak; Hartwig Huland; Ronald Simon; Thorsten Schlomm; Stefan Steurer
Journal:  Int J Mol Sci       Date:  2015-04-16       Impact factor: 5.923

10.  PIVOT and the challenges of localized prostate cancer care.

Authors:  Aviva E Weinberg; James D Brooks
Journal:  Transl Androl Urol       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.